{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-013553","form_type":"8-K","ticker":"SRTA","cik":"0001779128","company_name":"Strata Critical Medical, Inc.","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.147834+00:00","generated_at":"2026-05-15T22:18:52.179265+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Strata Critical Medical Q4 revenue up 83.5% YoY to $66.8M; raises FY2026 guidance","bullets":["Q4 2025 revenue $66.8M (+83.5% YoY); logistics revenue up 35.3% to $49.2M.","Full year 2025 revenue $197.1M, Adjusted EBITDA $14.1M, both above guidance high end.","Full year 2025 net loss from continuing ops $20.1M vs $16.1M in 2024.","FY2026 revenue guidance raised to $260-275M; Adjusted EBITDA guidance raised to $29-33M.","Clinical segment (Keystone) contributed $17.6M revenue in Q4; total gross profit $14.4M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-013553","json":"https://secwatch.observer/filing/0001628280-26-013553.json","markdown":"https://secwatch.observer/filing/0001628280-26-013553.md","text":"https://secwatch.observer/filing/0001628280-26-013553.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779128/000162828026013553/0001628280-26-013553-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779128/000162828026013553/srta-20260303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:18:52.179265+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}